Home / NXTCL.ST : STO

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does NXTCL.ST make money? Does NXTCL.ST have pricing power? What's the Earnings Whisper? Will NXTCL.ST profit more as the business scales? What is NXTCL.ST's management track record? Is NXTCL.ST's current price justified?

NextCell Pharma AB

SEK 0.23 -$0.47 (-67.24%)

STO · 30 Oct 2026 11:54 UTC

Previous Close

SEK 0.27

Day Range

SEK 0.20SEK 0.26

Year Range

SEK 0.20SEK 1.78

Market Cap

29.07M

AVG Volume

564.15K

Trailing/Forward PE

-0.6/0.14

PEG ratio

Dividend Yield

Next Earnings Date

2026-11-02

Primary Exchange

Stockholm Stock Exchange

Revenue (SEK) · Q

NXTCL.ST Revenue (SEK) by quarter
Period	Revenue (SEK)
26 Q3	3.03M
26 Q2	2.69M
26 Q1	1.77M
25 Q4	2.6M
25 Q3	2.26M
25 Q2	3.25M
25 Q1	2.83M
24 Q4	1.64M
24 Q3	2.44M
24 Q2	2.33M

Net Income (SEK) · Q

NXTCL.ST Net Income (SEK) by quarter
Period	Net Income (SEK)
26 Q3	-11.68M
26 Q2	-10.39M
26 Q1	-13.79M
25 Q4	-8.63M
25 Q3	-10.27M
25 Q2	-8.2M
25 Q1	-8.04M
24 Q4	-13.25M
24 Q3	-8.82M
24 Q2	-10.09M

Operating Income (SEK) · Q

NXTCL.ST Operating Income (SEK) by quarter
Period	Operating Income (SEK)
26 Q3	-11.69M
26 Q2	-10.64M
26 Q1	-14M
25 Q4	-8.84M
25 Q3	-10.35M
25 Q2	-8.61M
25 Q1	-8.28M
24 Q4	-13.61M
24 Q3	-9.03M
24 Q2	-10.4M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (SEK) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 2 Nov 2026.

No video analysis for this stock yet. Request one from our team.

AI Analysis

NextCell Pharma AB

Earnings: NXTCL.ST

Video analysis: NXTCL.ST

News: NXTCL.ST

Similar companies